186 related articles for article (PubMed ID: 31020570)
1. Increased Expression of MiR-27a and MiR-24-2 in Esophageal Squamous Cell Carcinoma.
Maghsudlu M; Farashahi Yazd E; Amiriani T
J Gastrointest Cancer; 2020 Mar; 51(1):227-233. PubMed ID: 31020570
[TBL] [Abstract][Full Text] [Related]
2. Identification of microRNAs as novel biomarkers for esophageal squamous cell carcinoma: a study based on The Cancer Genome Atlas (TCGA) and bioinformatics.
Li CY; Zhang WW; Xiang JL; Wang XH; Li J; Wang JL
Chin Med J (Engl); 2019 Sep; 132(18):2213-2222. PubMed ID: 31490264
[TBL] [Abstract][Full Text] [Related]
3. microRNA-195-Cdc42 axis acts as a prognostic factor of esophageal squamous cell carcinoma.
Sun N; Ye L; Chang T; Li X; Li X
Int J Clin Exp Pathol; 2014; 7(10):6871-9. PubMed ID: 25400770
[TBL] [Abstract][Full Text] [Related]
4. Integrated analysis of genome-wide miRNAs and targeted gene expression in esophageal squamous cell carcinoma (ESCC) and relation to prognosis.
Yang H; Su H; Hu N; Wang C; Wang L; Giffen C; Goldstein AM; Lee MP; Taylor PR
BMC Cancer; 2020 May; 20(1):388. PubMed ID: 32375686
[TBL] [Abstract][Full Text] [Related]
5. miR-145 expression level in tissue predicts prognosis of patients with esophageal squamous cell carcinoma.
Jin W; Luo W; Fang W; Wang Y; Wang L; Shen Q; Liu W; Zhang H
Pathol Res Pract; 2019 Jun; 215(6):152401. PubMed ID: 31014553
[TBL] [Abstract][Full Text] [Related]
6. Promoter hypomethylation mediated upregulation of MicroRNA-10b-3p targets FOXO3 to promote the progression of esophageal squamous cell carcinoma (ESCC).
Lu YF; Yu JR; Yang Z; Zhu GX; Gao P; Wang H; Chen SY; Zhang J; Liu MY; Niu Y; Wei XM; Wang W; Ye FJ; Zhang LX; Zhao Y; Sun GG
J Exp Clin Cancer Res; 2018 Dec; 37(1):301. PubMed ID: 30514328
[TBL] [Abstract][Full Text] [Related]
7. Downregulation of microRNA-382 is associated with poor outcome of esophageal squamous cell carcinoma.
Qi B; Lu JG; Yao WJ; Chang TM; Qin XG; Ji YH; Wang TY; Liu SG; Li HC; Liu YZ; Zhao BS
World J Gastroenterol; 2015 Jun; 21(22):6884-91. PubMed ID: 26078564
[TBL] [Abstract][Full Text] [Related]
8. Prognostic value of microRNA-100 in esophageal squamous cell carcinoma.
Zhou S; Yang B; Zhao Y; Xu S; Zhang H; Li Z
J Surg Res; 2014 Dec; 192(2):515-20. PubMed ID: 25218280
[TBL] [Abstract][Full Text] [Related]
9. Identification of miR-375 as a potential prognostic biomarker for esophageal squamous cell cancer: A bioinformatics analysis based on TCGA and meta-analysis.
Luo HS; Wu DH
Pathol Res Pract; 2019 Mar; 215(3):512-518. PubMed ID: 30638952
[TBL] [Abstract][Full Text] [Related]
10. Clinical potential of miR-3651 as a novel prognostic biomarker for esophageal squamous cell cancer.
Wang C; Guan S; Chen X; Liu B; Liu F; Han L; Un Nesa E; Song Q; Bao C; Wang X; Cheng Y
Biochem Biophys Res Commun; 2015 Sep; 465(1):30-4. PubMed ID: 26210449
[TBL] [Abstract][Full Text] [Related]
11. microRNA-27a functions as a tumor suppressor in esophageal squamous cell carcinoma by targeting KRAS.
Zhu L; Wang Z; Fan Q; Wang R; Sun Y
Oncol Rep; 2014 Jan; 31(1):280-6. PubMed ID: 24154848
[TBL] [Abstract][Full Text] [Related]
12. MiR-498 in esophageal squamous cell carcinoma: clinicopathological impacts and functional interactions.
Islam F; Gopalan V; Law S; Tang JC; Chan KW; Lam AK
Hum Pathol; 2017 Apr; 62():141-151. PubMed ID: 28188753
[TBL] [Abstract][Full Text] [Related]
13. Overexpression of miR-191 Predicts Poor Prognosis and Promotes Proliferation and Invasion in Esophageal Squamous Cell Carcinoma.
Gao X; Xie Z; Wang Z; Cheng K; Liang K; Song Z
Yonsei Med J; 2017 Nov; 58(6):1101-1110. PubMed ID: 29047233
[TBL] [Abstract][Full Text] [Related]
14. MiR-874-3p is an independent prognostic factor and functions as an anti-oncomir in esophageal squamous cell carcinoma via targeting STAT3.
Yuan RB; Zhang SH; He Y; Zhang XY; Zhang YB
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7265-7273. PubMed ID: 30468470
[TBL] [Abstract][Full Text] [Related]
15. Clinical significance of microRNA-34a in esophageal squamous cell carcinoma.
Lin X; Xu XY; Chen QS; Huang C
Genet Mol Res; 2015 Dec; 14(4):17684-91. PubMed ID: 26782413
[TBL] [Abstract][Full Text] [Related]
16. Expression Level of miR-34a in Tumor Tissue from Patients with Esophageal Squamous Cell Carcinoma.
Asadi M; Shanehbandi D; Mohammadpour H; Hashemzadeh S; Sepehri B
J Gastrointest Cancer; 2019 Jun; 50(2):304-307. PubMed ID: 29453761
[TBL] [Abstract][Full Text] [Related]
17. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma.
Wang WT; Guo CQ; Cui GH; Zhao S
World J Gastroenterol; 2019 Oct; 25(37):5604-5618. PubMed ID: 31602161
[TBL] [Abstract][Full Text] [Related]
18. LncRNA-TUSC7/miR-224 affected chemotherapy resistance of esophageal squamous cell carcinoma by competitively regulating DESC1.
Chang ZW; Jia YX; Zhang WJ; Song LJ; Gao M; Li MJ; Zhao RH; Li J; Zhong YL; Sun QZ; Qin YR
J Exp Clin Cancer Res; 2018 Mar; 37(1):56. PubMed ID: 29530057
[TBL] [Abstract][Full Text] [Related]
19. Upregulation of miR-519 enhances radiosensitivity of esophageal squamous cell carcinoma trough targeting PI3K/AKT/mTOR signaling pathway.
Zhang Y; Chen W; Wang H; Pan T; Zhang Y; Li C
Cancer Chemother Pharmacol; 2019 Dec; 84(6):1209-1218. PubMed ID: 31529206
[TBL] [Abstract][Full Text] [Related]
20. MicroRNA-367 is a potential diagnostic biomarker for patients with esophageal squamous cell carcinoma.
Sun J; Song K; Feng X; Gao S
Biochem Biophys Res Commun; 2016 Apr; 473(2):363-9. PubMed ID: 26777997
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
